Clinical Trial Update: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clopidogrel as adjunctive reperfusion therapy for acute coronary syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Acute Coronary Syndromes | Phase 3 | Status: COMPLETED